Shareholding Pattern

No data available at the moment
The promoters of Glenmark Pharma currently hold 46.65% of the company’s total shares.
Foreign Institutional Investors (FIIs) own 20.34%. Domestic Institutional Investors (DIIs) hold 2.49% of Glenmark Pharma.
The retail shareholding of Glenmark Pharma is 13.72%
The shareholding pattern of Glenmark Pharma is updated quarterly as per SEBI regulations.
Promoters (46.65%) | Mutual Funds (16.80%) | Retail and other (13.72%) |
Foreign institutions-FII (20.34%) | Other domestic institutions (2.49%) |